You are here

Article Text

Article menu
Download PDFPDF
PostScript
Letter
Variations in sex steroid priming for growth hormone stimulation testing in UK
  1. Carley Frerichs1,
  2. Lorna Raymond2,
  3. Senthil Senniappan1
  1. 1Department of Paediatric Endocrinology, Alder Hey Children's Hospital, Liverpool, UK
  2. 2University of Liverpool, Liverpool, UK
  1. Correspondence to Dr Senthil Senniappan, Department of Paediatric Endocrinology, Alder Hey Children's Hospital NHS Trust, Liverpool, UK; senthilkss{at}yahoo.co.uk

https://doi.org/10.1136/archdischild-2016-311186

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Identifying growth hormone deficiency (GHD) can be a diagnostic challenge. In clinical practice, it can be difficult to differentiate among GHD, idiopathic short stature or constitutional delay of growth and puberty. A combination of auxological data, insulin-like growth factor 1 activity, neuroimaging and detailed clinical history is used alongside growth hormone stimulation tests (GHSTs).

    There is variation in UK practice on how children are tested for GHD.1 GH treatment is expensive as well as burdensome to the patient.

    It is well known that sex steroids augment the GH response …

    View Full Text

    Footnotes

    • Contributors Survey was designed by LR and SS. Data were collected and analysed by CF. The paper and results were written by CF and overseen by SS.

    • Competing interests None.

    • Provenance and peer review Not commissioned; externally peer reviewed.

    • Data sharing statement Data are available only to authors.